Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS) SHH

Currency In CNY

AD

Valuation

Market Cap13.55B
Enterprise Value10.73B
P/E Ratio16.17
PEG Ratio-0.44
Price/Sales Ratio1.29
Price/Book Ratio0.82
Enterprise/Revenue0.88
Enterprise/EBITDA4.74

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.08
Operating Margin0.12
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.05

Income Statement

Revenue9.36B
Revenue/Share6.58
Gross Profit3.04B
EBITDA2.08B
Net Income944.38M
Diluted EPS0.7

Balance Sheet

Total Cash3.72B
Total Cash/Share2.78
Total Debt28.85M
Total Debt/Equity0
Current Ratio3.59
Book Value Per Share11.96

Price History

52-Week Change-18.56
52-Week High11.8
52-Week Low7.98
Moving Average 50 Days9.31
Moving Average 200 Days10.25

Statistics

Average Volume8.98M
Shares Outstanding1.34B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield3.53
Payout Ratio0.55
Last Split Factor2:1
Last Split DateMay 25, 2017
AD